Literature DB >> 29181178

Development of lymphoma from the donor of haploidentical stem cell transplantation: A case report.

Linna Xie1, Fang Zhou1.   

Abstract

Post-transplantation lymphoproliferative disease (PTLD) is a serious complication following hematopoietic stem cell transplantation (HSCT). The majority of the cases develop during the first year after the transplantation and are associated with reactivation of the Epstein-Barr virus (EBV); the EBV-induced lymphoproliferation usually includes donor-derived B cells. We herein describe the case of a 28-year-old female patient who developed EBV-negative PTLD, namely diffuse large B-cell lymphoma (DLBCL), 6 months after receiving a haploidentical HSCT from her father. Chimerism analysis performed with XY fluorescence in situ hybridization revealed a B-cell PTLD originating from the donor. Unfortunately, the donor also developed DLBCL 380 days after donating progenitor cells, although he was hematologically normal at the time of donation. The present case demonstrated that disease transmitted from the donor may be a possible cause of PTLD.

Entities:  

Keywords:  haploidentical stem cell transplantation; lymphoma; post-transplantation lymphoproliferative disorder

Year:  2017        PMID: 29181178      PMCID: PMC5700284          DOI: 10.3892/mco.2017.1414

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  20 in total

1.  Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.

Authors:  D M Knowles; E Cesarman; A Chadburn; G Frizzera; J Chen; E A Rose; R E Michler
Journal:  Blood       Date:  1995-01-15       Impact factor: 22.113

2.  Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease.

Authors:  R Mañez; M C Breinig; P Linden; J Wilson; J Torre-Cisneros; S Kusne; S Dummer; M Ho
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

3.  Molecular genetic analysis of lymphoid tumors arising after organ transplantation.

Authors:  J Locker; M Nalesnik
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

4.  Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

Authors:  Andrew M Evens; Kevin A David; Irene Helenowski; Beverly Nelson; Dixon Kaufman; Sheetal M Kircher; Alla Gimelfarb; Elise Hattersley; Lauren A Mauro; Borko Jovanovic; Amy Chadburn; Patrick Stiff; Jane N Winter; Jayesh Mehta; Koen Van Besien; Stephanie Gregory; Leo I Gordon; Jamile M Shammo; Scott E Smith; Sonali M Smith
Journal:  J Clin Oncol       Date:  2010-01-19       Impact factor: 44.544

5.  Transplant tumor registry: donor related malignancies.

Authors:  H Myron Kauffman; Maureen A McBride; Wida S Cherikh; Pamela C Spain; William H Marks; Allan M Roza
Journal:  Transplantation       Date:  2002-08-15       Impact factor: 4.939

6.  Clinical characteristics of monomorphic post-transplant lymphoproliferative disorders.

Authors:  Jung-Hye Choi; Byeong-Bae Park; Cheolwon Suh; Jong-Ho Won; Won-Sik Lee; Ho-Jin Shin
Journal:  J Korean Med Sci       Date:  2010-03-23       Impact factor: 2.153

7.  Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease.

Authors:  A Savoie; C Perpête; L Carpentier; J Joncas; C Alfieri
Journal:  Blood       Date:  1994-05-01       Impact factor: 22.113

8.  Leukemia in donor cells after allogeneic hematopoietic stem cell transplant.

Authors:  C G Brunstein; B A Hirsch; D Hammerschmidt; R C McGlennen; P L Nguyen; C M Verfaillie
Journal:  Bone Marrow Transplant       Date:  2002-06       Impact factor: 5.483

9.  Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.

Authors:  D W Hanto; G Frizzera; D T Purtilo; K Sakamoto; J L Sullivan; A K Saemundsen; G Klein; R L Simmons; J S Najarian
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

10.  Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients.

Authors:  G Frizzera; D W Hanto; K J Gajl-Peczalska; J Rosai; R W McKenna; R K Sibley; K P Holahan; L L Lindquist
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.